Mutation feature analysis of PPP1R14B in pan-cancer suggested that the highest alteration frequency of PPP1R14B (>4%) appears for patients with bladder/urinary tract cancer with “Amplification” as the primary type, and the genetic alteration of PPP1R14B in tumors changed its mRNA expression. Here, PPP1R14B is linked to cancer.